logo
  

Roche To Buy TIB Molbiol For Undisclosed Terms - Quick Facts

Swiss drug major Roche (RHHBY) announced Thursday that it has signed a definitive share purchase agreement to acquire long-term partner TIB Molbiol Group. The financial terms of the deal were not disclosed.

With the acquisition, the company aims to expand PCR-test portfolio in the fight against new infectious diseases.

The deal is expected to close in the fourth quarter subject to customary conditions.

Roche expects the acquisition of TIB Molbiol to enhance its broad portfolio of molecular diagnostics solutions with a wide range of assays for infectious diseases, such as the identification of SARS-CoV-2 variants.

Both companies have collaborated for more than 20 years. TIB Molbiol's comprehensive portfolio of over 45 CE-IVD assays and more than 100 research use assays are already available on Roche's large installed base of LightCycler PCR systems and MagNA Pure sample preparation systems.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Royal Caribbean Group's ultra-luxury brand Silversea Cruises is set to launch the world's first hybrid-powered cruise ship in the summer of 2023. This will also be the first ship with large-scale fuel cell technology to enable emission-free port operations. The fuel cells will provide 100% of power while at port. Affco USA is recalling around 24,461 pounds of frozen raw lamb shoulder products that were not presented for import re-inspection into the U.S., the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. The recall involves the frozen raw lamb shoulder items that were imported on July 12, 2021. American Express Company (AXP) reported an increase in profit for the third quarter that also topped Wall Street estimates. Consolidated total revenues net of interest expense rose 25 percent year-on-year, primarily reflecting growth in Card Member spending, as well as a rise in the average discount...
Follow RTT